Transcend CPAP Starter System
by Somnetics International, Inc
Transcend CPAP Starter System (503042) is a Class II device made by Somnetics International, Inc, cleared under FDA 510(k) K100121 on 13 Jul 2010 and listed in FDA GUDID since 24 Sep 2016 (UDI-DI M9505030420), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | NumberM9505030420 | Date24 Sep 2016 | StatusListed |
| United States | FDA 510(k)SESE | NumberK100121 | Date13 Jul 2010 | StatusActive |
Official records
- FDA 510(k) database K100121
Across registries
- FDA 510(k) K100121 decided 13 Jul 2010 Active
- FDA GUDID UDI-DI M9505030420 listed 24 Sep 2016 Listed
Timeline
- Cleared FDA 510(k) K100121
- Listed FDA GUDID M9505030420
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Transcend
- Generic name
- Home CPAP unit
- Model / Ref / Catalog
- CPAP Starter System, 503042
- Primary DI / UDI-DI
- M9505030420
- 510(k) Number
- FDA product code
- BZD
- GMDN term
- Home CPAP unit
- Device class
- Class II
- Regulation number
- 868.5905
- GUDID distribution status
- In Commercial Distribution
- Size
- Length — 11.5 InchWidth — 9.5 InchHeight — 4.5 Inch
Similar devices
Other devices filed under FDA product code BZD (Ventilator, Non-Continuous (Respirator)).
- MIRAGE LIBERTY FULL FACE MASK by Resmed Corp
- F&P 950 Accessory Breathing Circuit Kits by FISHER & PAYKEL HEALTHCARE, INC.
- DreamStation EUX700H15 by Respironics Inc.
- ARIA LX CPAP SYSTEM by Respironics, Inc.
- DreamWear 00 1146449 by Respironics Inc.
- Novaplus Hospital Nasal Vented Mask, s/m 50155 by Sleepnet Corporation
- TASMAN by Resmed Corp
- MALLINCKRODT, GOODKNIGHT 418A, GOODKNIGHT 418P, SILVERLINING 2 by Nellcor Puritan Bennett France Dvpt.
- TAP PAP NASAL PILLOW MASK by AIRWAY MANAGEMENT INC
- MODEL 7410 VOYAGER by Healthdyne Technologies, Inc.